Literature DB >> 6871351

Group sequential clinical trials with triangular continuation regions.

J Whitehead, I Stratton.   

Abstract

In this paper a new class of group sequential procedures for clinical trials is introduced, and the use of these procedures is illustrated by reference to a recently completed comparative study. In a group sequential trial the decision to stop or to continue is made at regular intervals throughout the trial, but not as frequently as after every patient response. This more practical formulation retains most of the advantages of sequential analysis, particularly the economy in sample size. Comparisons are made with group sequential designs derived from the repeated significance test.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871351

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  24 in total

1.  Combining an Internal Pilot with an Interim Analysis for Single Degree of Freedom Tests.

Authors:  John A Kairalla; Keith E Muller; Christopher S Coffey
Journal:  Commun Stat Theory Methods       Date:  2010-12-01       Impact factor: 0.893

2.  Nonparametric sequential evaluation of diagnostic biomarkers.

Authors:  Aiyi Liu; Chengqing Wu; Enrique F Schisterman
Journal:  Stat Med       Date:  2008-05-10       Impact factor: 2.373

3.  Monitoring for lack of benefit: a critical component of a randomized clinical trial.

Authors:  Boris Freidlin; Edward L Korn
Journal:  J Clin Oncol       Date:  2008-12-08       Impact factor: 44.544

4.  Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.

Authors:  D C Rowe-Jones; A L Peel; R D Kingston; J F Shaw; C Teasdale; D S Cole
Journal:  BMJ       Date:  1990-01-06

5.  Selected list of books and journals for the small medical library.

Authors:  A N Brandon; D R Hill
Journal:  Bull Med Libr Assoc       Date:  1985-04

6.  Adaptive designs for comparative effectiveness research trials.

Authors:  John A Kairalla; Christopher S Coffey; Mitchell A Thomann; Ronald I Shorr; Keith E Muller
Journal:  Clin Res Regul Aff       Date:  2014-11-13

7.  Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials.

Authors:  Lingling Li; Scott R Evans; Hajime Uno; L J Wei
Journal:  Stat Biopharm Res       Date:  2009-11-01       Impact factor: 1.452

8.  Group Sequential Design for Randomized Phase III Trials under the Weibull Model.

Authors:  Jianrong Wu; Xiaoping Xiong
Journal:  J Biopharm Stat       Date:  2014-10-16       Impact factor: 1.051

9.  More data, less information? Potential for nonmonotonic information growth using GEE.

Authors:  Abigail B Shoben; Kyle D Rudser; Scott S Emerson
Journal:  J Biopharm Stat       Date:  2016-04-06       Impact factor: 1.051

10.  Group Sequential Survival Trial Design and Monitoring Using the Log-Rank Test.

Authors:  Jianrong Wu; Xiaoping Xiong
Journal:  Stat Biopharm Res       Date:  2017-03-02       Impact factor: 1.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.